Atrial fibrillation (Part 1): Pathophysiology, risk factors, and therapeutic basis
Atrial fibrillation is the most common sustained arrhythmia in clinical practice, with a
preference for older age groups. Considering population ageing, the projections for the next …
preference for older age groups. Considering population ageing, the projections for the next …
[HTML][HTML] Fibrilação atrial (Parte 1): fisiopatologia, fatores de risco e bases terapêuticas
A fibrilação atrial é a arritmia sustentada mais comum na prática clínica com predileção
pelas faixas etárias mais avançadas. Com o envelhecimento populacional, as projeções …
pelas faixas etárias mais avançadas. Com o envelhecimento populacional, as projeções …
Prevalence of atrial fibrillation and stroke risk assessment based on telemedicine screening tools in a primary healthcare setting
ERFL de Moraes, C Cirenza, RD Lopes… - European journal of …, 2019 - Elsevier
Background Worldwide atrial fibrillation (AF) prevalence varies between 0.1% and 4.0%,
and has been increasing. Little is known about the prevalence of AF in Brazil. Our objective …
and has been increasing. Little is known about the prevalence of AF in Brazil. Our objective …
[HTML][HTML] Identification of key immune-related genes and immune infiltration in atrial fibrillation with valvular heart disease based on bioinformatics analysis
S Li, Z Jiang, X Chao, C Jiang… - Journal of Thoracic …, 2021 - ncbi.nlm.nih.gov
Background Atrial fibrillation (AF) is the most common persistent arrhythmia. Valvular heart
disease (VHD) and AF frequently coexist. In our study, from performing bioinformatics …
disease (VHD) and AF frequently coexist. In our study, from performing bioinformatics …
[HTML][HTML] Updated geriatric cardiology guidelines of the Brazilian Society of Cardiology-2019
Updated Geriatric Cardiology Guidelines of the Brazilian Society of Cardiology - 2019 - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Comparison of the new oral anticoagulants and warfarin in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis
Y de Souza Lima Bitar, MG Neto, JAL Filho, LV Pereira… - Drugs in R&D, 2019 - Springer
Abstract Introduction New oral anticoagulants (NOACs) are approved for use in nonvalvular
atrial fibrillation (AF). Objectives This study aimed to evaluate the efficacy and safety of …
atrial fibrillation (AF). Objectives This study aimed to evaluate the efficacy and safety of …
Atualização das Diretrizes em Cardiogeriatria da Sociedade Brasileira de Cardiologia–2019
A partir da segunda metade do século XX, a sobrevivência democratizou-se em grande
parte dos países do mundo. Isto é, mais pessoas estão alcançando as idades mais …
parte dos países do mundo. Isto é, mais pessoas estão alcançando as idades mais …
A program to optimize the detection of paroxysmal atrial fibrillation: the RITMO study
Background: Atrial fibrillation (AF) is the most common sustained arrythmia, but still
underdiagnosed especially among asymptomatic patients. Objectives: To evaluate a simple …
underdiagnosed especially among asymptomatic patients. Objectives: To evaluate a simple …
Quality of Oral Anticoagulation in Atrial Fibrillation Patients at a Tertiary Hospital in Brazil
KNDS Malagutte, CFSMP Silveira, FM Reis… - Arquivos Brasileiros …, 2022 - SciELO Brasil
Background: Atrial fibrillation (AF) affects 0.5% to 2.0% of the general population and is
usually associated with cardiac structural diseases, hemodynamic damage, and …
usually associated with cardiac structural diseases, hemodynamic damage, and …
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and stage 5 chronic kidney disease under dialysis: A systematic review and …
LA de Lucena, MAA Freitas, AKC Souza… - Journal of Thrombosis …, 2024 - Springer
Background In patients with atrial fibrillation (AF) and normal or slightly impaired renal
function, the use of direct oral anticoagulants (DOACs) is preferable to vitamin K antagonists …
function, the use of direct oral anticoagulants (DOACs) is preferable to vitamin K antagonists …